-+ 0.00%
-+ 0.00%
-+ 0.00%

REDHILL BIOPHARMA: IN VIVO RESULTS INDICATE OPAGANIB WITH VENETOCLAX REDUCES CHRONIC LYMPHOCYTIC LEUKEMIA CELLS BY HALF COMPARED TO CONTROLS

路透·12/15/2025 12:00:39

登錄查看新聞詳情